Abstract: The present invention relates to the method of treating heavy menstrual bleeding in a subject with or without uterine fibroids and in need of treatment by administering an effective amount of 4-((R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens.

Abstract: The present invention relates to the method of treating heavy menstrual bleeding in a subject with or without uterine fibroids and in need of treatment by administering an effective amount of 4-((R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens.

Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.

Abstract: The present invention relates to the method of treating heavy menstrual bleeding in a subject with or without uterine fibroids and in need of treatment by administering an effective amount of 4-((R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens.

Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.

Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.

Abstract: Systems, methods, and computer program products are provided for a comprehensive software security system. The overarching software security system described and claimed herein provides for a system that address all of the concerns and vulnerabilities present at the design level (i.e., new software applications) and the production level (i.e., pre-existing software applications) associated with software. Additionally, the system governs the individual security processes and practices. The software security system defines specific security practices and the timing for application of the practices within the overall software development lifecycle. Additionally, the disclosed software security system takes advantage of role specialization, such as security specialization, to increase effectiveness and limit conflicts of interest within the design process.

Abstract: The invention relates to a method and kit for identifying chronic or acute mammalian wound tissue or for determining the prognosis of mammalian wound tissue based upon the identification of at least one key set of molecular markers or genes whose expression pattern is indicative of a given wound type and so representative of a given prognosis.

Abstract: Systems, methods, and computer program products are provided for a comprehensive software security system. The overarching software security system described and claimed herein provides for a system that address all of the concerns and vulnerabilities present at the design level (i.e., new software applications) and the production level (i.e., pre-existing software applications) associated with software. Additionally, the system governs the individual security processes and practices. The software security system defines specific security practices and the timing for application of the practices within the overall software development lifecycle. Additionally, the disclosed software security system takes advantage of role specialization, such as security specialization, to increase effectiveness and limit conflicts of interest within the design process.

Abstract: A body weight support system that monitors and controls the level of support force within a stepcycle to result in normative center of mass movement and ground reaction forces. The system comprises a harness connected to a lift line which in turn is connected to a means for advancing and retracting the lift line. A control system is configured to monitor load on the cable and to regulate lift line advancement and retraction in response to load information. The support system can be combined with a treadmill for locomotor training of a subject.

Abstract: A body weight support system that monitors and controls the level of support force within a stepcycle to result in normative center of mass movement and ground reaction forces. The system comprises a harness connected to a lift line which in turn is connected to a means for advancing and retracting the lift line. A control system is configured to monitor load on the cable and to regulate lift line advancement and retraction in response to load information. The support system can be combined with a treadmill for locomotor training of a subject.